BMY – Bristol Myers Squibb Co.
(36 Total) [click headers to sort columns]
| Symbol: | BMY |
| Last: | 24.92 |
| Date: | 7/30/2010 |
| Time: | 4:00pm |
| Change: | -0.16 |
| Open: | 24.98 |
| High: | 25.13 |
| Low: | 24.78 |
| Volume: | 11,438,207 |
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | Earnings Rank | Strength Rank | PES | Avg Vol |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/23/10 | E | BMY – Bristol Myers Squibb Co. | MED | 24.93 | .54/.48 | 4768 | +12.5- | +2.2- | 8.0 | 6.7 | 46 | 16,133,000 |
| 04/30/10 | E | BMY – Bristol Myers Squibb Co. | MED | 25.37 | .57/.42 | 4807 | +35.7+ | +11+ | 8.4 | 3.8 | 45 | 12,858,000 |
| 01/29/10 | E | BMY – Bristol Myers Squibb Co. | MED | 24.10 | .47/.40 | 5033 | +17.5- | +11+ | 8.2 | 4.5 | 51 | 25,663,000 |
| 10/23/09 | E | BMY – Bristol Myers Squibb Co. | MED | 22.46 | .52/.45 | 5487 | +15.6- | +4.4+ | 8.3 | 2.7 | 43 | 10,785,000 |
| 07/24/09 | E | BMY – Bristol Myers Squibb Co. | MED | 20.86 | .56/.43 | 5384 | +30.2+ | +3.5+ | 8.1 | 3.3 | 37 | 13,662,000 |
| 04/29/09 | E | BMY – Bristol Myers Squibb Co. | MED | 19.65 | .48/.39 | 5015 | +23.1- | +2.5- | 7.8 | 5.1 | 41 | 16,476,000 |
| 01/28/09 | E | BMY – Bristol Myers Squibb Co. | MED | 23.13 | .46/.30 | 5249 | +53.3+ | +3.8- | 7.5 | 9.2 | 50 | 18,302,000 |
| 10/24/08 | E | BMY – Bristol Myers Squibb Co. | MED | 18.05 | .46/.33 | 5254 | +39.4- | +14- | 7.2 | 7.1 | 39 | 15,053,000 |
| 07/25/08 | E | BMY – Bristol Myers Squibb Co. | MED | 22.12 | .43/.31 | 5203 | +38.7+ | +16- | 6.8 | 4.8 | 51 | 14,352,000 |
| 04/25/08 | E | BMY – Bristol Myers Squibb Co. | MED | 22.21 | .42/.36 | 5181 | +16.7- | +20- | 6.8 | 3.1 | 53 | 12,983,000 |
| 02/01/08 | EX2 | BMY – Bristol Myers Squibb Co. | MED | 23.02 | .33/.17 | 5381 | +94.1+ | +33+ | 8.0 | 2.9 | 70 | 15,649,000 |
| 10/26/07 | EX2 | BMY – Bristol Myers Squibb Co. | MED | 29.36 | .38/.22 | 5050 | +72.7+ | +22+ | 6.4 | 6.4 | 77 | 11,196,000 |
| 07/27/07 | EX1 | BMY – Bristol Myers Squibb Co. | MED | 29.85 | .36/.34 | 4928 | +5.9- | +1.2+ | 5.4 | 7.2 | 83 | 11,281,000 |
| 04/27/07 | EX1 | BMY – Bristol Myers Squibb Co. | MED | 29.23 | .38/.32 | 4476 | +18.8+ | -4.3+ | 4.0 | 6.8 | 77 | 9,907,000 |
| 01/26/07 | E | bmy – Bristol Myers Squibb Co. | MED | 26.28 | .19/.30 | 4213 | -36.7- | -16- | 2.1 | 6.0 | 138 | 7,172,000 |
| 10/27/06 | E | bmy – Bristol Myers Squibb Co. | MED | 24.53 | .22/.31 | 4154 | -29- | -13- | 2.3 | 4.2 | 112 | 12,653,000 |
| 07/28/06 | E | bmy – Bristol Myers Squibb Co. | MED | 24.04 | .35/.47 | 4871 | -25.5- | -0.4- | 2.6 | 5.7 | 69 | 6,700,000 |
| 04/28/06 | EX1 | bmy – Bristol Myers Squibb Co. | MED | 25.27 | .32/.34 | 4676 | -5.9+ | +3.2+ | 1.8 | 4.8 | 79 | 8,090,000 |
| 01/26/06 | E | bmy – Bristol Myers Squibb Co. | MED | 21.97 | .30/.39 | 5019 | -23.1+ | -2.7- | 2.5 | 1.7 | 73 | 8,976,000 |
| 10/31/05 | E | bmy – Bristol Myers Squibb Co. | MED | 21.14 | .31/.44 | 4767 | -29.6- | -0.2- | 2.4 | 1.9 | 68 | 6,273,000 |
| 07/29/05 | EX1 | BMY – Bristol Myers Squibb Co. | MED | 25.17 | .47/.46 | 4889 | +2.2+ | +1.5+ | 2.7 | 3.4 | 54 | 4,381,000 |
| 04/29/05 | E | bmy – Bristol Myers Squibb Co. | MED | 25.70 | .34/.41 | 4532 | -17.1- | -2- | 2.3 | 7.1 | 76 | 5,756,000 |
| 01/28/05 | EX1 | bmy – Bristol Myers Squibb Co. | MED | 24.09 | .39/.43 | 5157 | -9.3- | +1.6+ | 2.7 | 2.8 | 62 | 5,707,000 |
| 11/01/04 | E | bmy – Bristol Myers Squibb Co. | MED | 23.43 | .44/.48 | 5427 | -8.3- | +1- | 2.7 | 2.7 | 53 | 5,030,000 |
| 07/30/04 | E | BMY – Bristol Myers Squibb Co. | MED | 22.57 | .46/.45 | 5430 | +2.2 | +5.9- | 2.6 | 2.2 | 49 | 5,020,000 |
| 04/29/04 | E | bmy – Bristol Myers Squibb Co. | MED | 25.48 | .41/.41 | 5181 | +0- | +9.6- | 4.6 | 2.0 | 62 | 7,575,000 |
| 01/30/04 | E | BMY – Bristol Myers Squibb Co. | MED | 28.82 | .37/.19 | 5571 | +94.7- | +16- | 6.1 | 3.3 | 78 | 6,209,000 |
| 10/24/03 | E | BMY – Bristol Myers Squibb Co. | MED | 25.10 | .47/.17 | 5337.0 | +176+ | +17.6- | 7.5 | 1.7 | 53 | 5,543,000 |
| 07/25/03 | EX3 | BMY – Bristol Myers Squibb Co. | MED | 26.44 | .45/.25 | 5052.0 | +80+ | +22+ | 5.4 | 3.9 | 59 | 5,618,000 |
| 04/30/03 | E | bmy – Bristol Myers Squibb Co. | MED | 25.21 | .39/.43 | 4711.0 | -9 | +1- | 4.7 | 5.2 | 65 | 5,056,000 |
| 03/11/03 | E | bmy – Bristol Myers Squibb Co. | MED | 22.51 | 0.8 | 3.0 | 0 | 5,056,000 | ||||
| 10/25/02 | EX1 | bmy – Bristol Myers Squibb Co. | MED | 24.17 | .26/.64 | 4171.0 | -59+ | -12+ | 1.3 | 3.8 | 93 | 5,056,000 |
| 07/24/02 | E | bmy – Bristol Myers Squibb Co. | MED | 21.10 | .23/.57 | 4053.0 | -60- | -14- | 2.2 | 1.4 | 92 | 8,943,000 |
| 04/26/02 | E | bmy – Bristol Myers Squibb Co. | MED | 29.89 | .30/.64 | 4082.0 | -53 | -13- | 4.4 | 0.8 | 100 | 10,273,000 |
| 01/25/02 | EX1 | bmy – Bristol Myers Squibb Co. | MED | 46.85 | -.54/.55 | 5282.0 | +10+ | 7.8 | 1.9 | -87 | 6,585,000 | |
| 10/24/01 | E | BMY – Bristol Myers Squibb Co. | MED | 58.02 | .64/.58 | 4743.0 | +10 | +4 | 8.6 | 6.8 | 91 | 4,732,000 |
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | ER | SR | PES | Avg Vol |